Skip to main content

Advertisement

Log in

p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Despite total surgical resection, a percentage of meningiomas do unexpectedly recur. At present the prediction of recurrence risk and the management of recurrent tumours represent major issues in the patients affected by meningiomas. The present study aims at investigating the prognostic value of the expression of the phosphorylated transcription factor cyclic AMP responsive element binding protein (p-CREB) in a series of meningiomas of different histotype and grade. While no p-CREB expression was found in specimens of normal leptomeninges, 71 % of meningiomas in our cohort expressed p-CREB. In addition, nuclear expression of p-CREB was present in the endothelia of tumor vessels in all of the meningiomas, but not in the vessels of the non-neoplastic meninges. High expression of p-CREB was significantly more frequent in meningiomas showing atypical, chordoid or microcystic histotype (P = 0.0003), high histological grade (P < 0.0001), high Ki-67 labeling index (P = 0.0001), high microvessel density counts (P < 0.0001) and high vascular endothelial growth factor expression (P = 0.0113). In addition, high p-CREB expression was significantly associated with the development of recurrences (P = 0.0031) and it was a significant negative, albeit not independent, prognostic factor for disease free survival in patients with meningiomas submitted to complete surgical removal (P = 0.0019). In conclusion, we showed that p-CREB is expressed in human meningiomas and that it represents a significant predictor of recurrence risk in these tumors. Due to its high expression in more aggressive tumors and in the tumor vessels, it may represent a novel therapeutic target in meningiomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Perry A, Louis DN, Scheithauer BW et al (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumors of the central nervous system. IARCC Press, Lyon, pp 164–172

    Google Scholar 

  2. Perry A, Stafford SL, Scheithauer BW, Lohse CM, Wollan PC (1999) “Malignancy” in meningiomas: a clinico-pathological study of 116 patients with grading implications. Cancer 85:2046–2056

    CAS  PubMed  Google Scholar 

  3. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Stafford SL, Pollock BE, Foote RL et al (2001) Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 49:1029–1037

    CAS  PubMed  Google Scholar 

  5. Monleòn D, Morales JM, Gonzalez-Segura A et al (2010) Metabolic aggressiveness in benign meningiomas with chromosomal instabilities. Cancer Res 70:8426–8434

    Article  PubMed  Google Scholar 

  6. Lonze BE, Ginty DD (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605–623

    Article  CAS  PubMed  Google Scholar 

  7. Montminy MR, Bilezikjian LM (1987) Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328:175–178

    Article  CAS  PubMed  Google Scholar 

  8. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD (1999) Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286:2358–2361

    Article  CAS  PubMed  Google Scholar 

  9. Ionescu AM, Schwarz EM, Vinson C et al (2001) PTHrP modulates chondrocyte differentiation through AP-1 and CREB signaling. J Biol Chem 276:11639–11647

    Article  CAS  PubMed  Google Scholar 

  10. Shankar DB, Sakamoto KM (2004) The role of cyclic-AMP binding protein (CREB) in leukemia cell proliferation and acute leukemias. Leuk Lymphoma 45:265–270

    Article  CAS  PubMed  Google Scholar 

  11. Conkright MD, Montminy M (2005) CREB: the unindicted cancer co-conspirator. Trends Cell Biol 15:457–459

    Article  CAS  PubMed  Google Scholar 

  12. Rosenberg D, Groussin L, Jullian E, Perlemoine K et al (2002) Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann N Y Acad Sci 968:65–74

    Article  CAS  PubMed  Google Scholar 

  13. Wu D, Zhau HE, Huang WC, Iqbal S, Habib FK, Sartor O, Cvitanovic L, Marshall FF, Xu Z, Chung LW (2007) cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis. Oncogene 26:5070–5077

    Article  CAS  PubMed  Google Scholar 

  14. Chhabra A, Fernando H, Watkins G, Mansel RE et al (2007) Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis. Oncol Rep 18:953–958

    CAS  PubMed  Google Scholar 

  15. Pigazzi M, Ricotti E, Germano G, Faggian D et al (2007) cAMP response element binding protein (CREB) overexpression CREB has been described as critical for leukemia progression. Haematologica 92:1435–2437

    Article  CAS  PubMed  Google Scholar 

  16. Seo HS, Liu DD, Bekele BN, Kim MK, Pisters K, Lippman SM, Wistuba II, Koo JS (2008) Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer. Cancer Res 68:6065–6073

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Linnerth NM, Greenaway JB, Petrik JJ, Moorehead RA (2008) cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation. Int J Gynecol Cancer 18:1248–1257

    Article  CAS  PubMed  Google Scholar 

  18. Zucman J, Delattre O, Desmaze C, Epstein AL et al (1993) EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 4:341–345

    Article  CAS  PubMed  Google Scholar 

  19. Abramovitch R, Tavor E, Jacob-Hirsch J, Zeira E, Amariglio N, Pappo O et al (2004) A pivotal role of cyclic AMP responsive element binding protein in tumor progression. Cancer Res 64:1338–1346

    Article  CAS  PubMed  Google Scholar 

  20. Kinjo K, Sandoval S, Sakamoto KM, Shankar DB (2005) The role of CREB as a proto-oncogene in hematopoiesis. Cell Cycle 4:1134–1135

    Article  CAS  PubMed  Google Scholar 

  21. Uhlen M, Oksvold P, Fagerberg L, Lundberg E et al (2010) Towards a knowledge-based human protein atlas. Nat Biotechnol 28:1248–1250

    Article  CAS  PubMed  Google Scholar 

  22. Mantamadiotis T, Papalexis N, Dworkin S (2012) CREB signalling in neural stem/progenitor cells: recent developments and the implications for brain tumour biology. BioEssays 34:293–300

    Article  CAS  PubMed  Google Scholar 

  23. Tan X, Wang S, Zhu L, Wu C, Yin B, Zhao J, Yuan J, Qiang B, Peng X (2012) cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a. Proc Natl Acad Sci USA 109:15805–15810

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Sakamoto KM, Frank DA (2009) CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin Cancer Res 15:2583–2587

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Xiao X, Li BX, Mitton B, Ikeda A et al (2010) Targeting CREB for cancer therapy: friend or foe. Curr Cancer Drug Targets 10:384–391

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Malla R, Gopinath S, Alapati K, Gondi CS et al (2010) Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3 K/Akt pathway in gliomas. PLoS One 5:e13731

    Article  PubMed Central  PubMed  Google Scholar 

  27. Barresi V, Cerasoli S, Vitarelli E, Tuccari G (2007) Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol 114:147–156

    Article  CAS  PubMed  Google Scholar 

  28. Barresi V, Vitarelli E, Cerasoli S (2009) Semaphorin3A immunohistochemical expression in human meningiomas, correlation with the microvessel density. Virchows Arch 454:563–571

    Article  CAS  PubMed  Google Scholar 

  29. Barresi V, Tuccari G (2010) Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas. Neuropathology 30:537–546

    Google Scholar 

  30. Barresi V, Mondello S, Branca G, Rajan TS, Vitarelli E, Tuccari G (2014) p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma. Hum Pathol. doi:10.1016/j.humpath.2014.10.011

    Google Scholar 

  31. Barresi V, Alafaci C, Salpietro F, Tuccari G (2008) Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade; proliferation or microvessel density? Oncol Rep 20:485–492

    CAS  PubMed  Google Scholar 

  32. Barresi V, Cerasoli S, Tuccari G (2008) Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas. Neuropathology 28:472–478

    Article  PubMed  Google Scholar 

  33. Barresi V, Vitarelli E, Tuccari G, Barresi G (2008) Correlative study of microvessel density and 5-lipoxygenase expression in human sporadic colorectal cancer. Arch Pathol Lab Med 132:1807–1812

    PubMed  Google Scholar 

  34. Barresi V, Tuccari G, Barresi G (2009) Adiponectin immunohistochemical expression in colorectal cancer and its correlation with histological grade and tumor microvessel density. Pathology 41:533–538

    Article  PubMed  Google Scholar 

  35. Barresi V, Di Gregorio C, Regiani-Bonetti L, Ponz-De Leon M, Barresi G, Vitarelli E (2010) Stage I colorectal carcinoma, VEGF immunohistochemical expression; microvessel density; and their correlation with clinical outcome. Virchows Arch 457:11–19

    Article  CAS  PubMed  Google Scholar 

  36. Barresi V (2011) Angiogenesis in meningiomas. Brain Tumor Pathol 28:99–106

    Article  CAS  PubMed  Google Scholar 

  37. Barresi V, Branca G, Granata F, Alafaci C, Caffo M, Tuccari G (2013) Embolized meningiomas, risk of overgrading and neo-angiogenesis. J Neurooncol 113:207–219

    Article  PubMed  Google Scholar 

  38. Rudolph D, Tafuri A, Gass P, Hammerling GJ, Arnold B, Schutz G (1998) Impaired fetal T cell development and mice lethality in mice lacking cAMP response element binding protein. Proc Natl Acad Sci USA 95:4481–4486

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Shiga H, Asou H, Ito E (2005) Advancement of differentiation of oligodendrocyte progenitor cells by a cascade including protein kinase A and cyclic AMP-response element binding protein. Neurosci Res 53:436–441

    Article  CAS  PubMed  Google Scholar 

  40. Yu L, Guo X, Zhang P, Qi R, Li Z, Zhang S (2014) Cyclic adenosine monophosphate-responsive element-binding protein activation predicts an unfavorable prognosis in patients with hepatocellular carcinoma. Onco Targets Ther 29:873–879

    Google Scholar 

  41. Zhang JQ, Yao QH, Kuang YQ, Ma Y, Yang LB, Huang HD, Cheng JM, Yang T, Liu EY, Liang L, Fan KX, Zhao K, Xia X, Gu JW (2014) Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma. Hum Pathol. doi:10.1016/j.humpath.2014.01.025

    Google Scholar 

  42. Daniel P, Filiz G, Brown DV, Hollande F, Gonzales M, D’Abaco G, Papalexis N, Phillips WA, Malaterre J, Ramsay RG, Matmandiotis T (2014) Selective CREB-dependent cyclin expression mediated by the PI3 K and MAPK pathways supports glioma cell proliferation. Oncogenesis. doi:10.10138/oncsis.2014.21

    PubMed Central  PubMed  Google Scholar 

  43. Christov C, Lechapt-Zalcman E, Adle-Biassette H, Nachev S, Gherardi RK (1999) Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas. Acta Neuropathol 98:414–420

    Article  CAS  PubMed  Google Scholar 

  44. Mayo LD, Kessler KM, Pincheira R, Warren RS, Donner DB (2001) Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase. J Biol Chem 276:25184–25189

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflict of interest or funding to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valeria Barresi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barresi, V., Branca, G., Caffo, M. et al. p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk. J Neurooncol 122, 87–95 (2015). https://doi.org/10.1007/s11060-014-1706-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-014-1706-9

Keywords

Navigation